![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: CCDC102B |
Gene summary for CCDC102B |
![]() |
Gene information | Species | Human | Gene symbol | CCDC102B | Gene ID | 79839 |
Gene name | coiled-coil domain containing 102B | |
Gene Alias | ACY1L | |
Cytomap | 18q22.1-q22.2 | |
Gene Type | protein-coding | GO ID | GO:0003674 | UniProtAcc | Q68D86 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
79839 | CCDC102B | ATC11 | Human | Thyroid | ATC | 1.02e-03 | 3.45e-01 | 0.3386 |
79839 | CCDC102B | ATC12 | Human | Thyroid | ATC | 1.09e-24 | 7.71e-01 | 0.34 |
79839 | CCDC102B | ATC13 | Human | Thyroid | ATC | 3.42e-58 | 1.18e+00 | 0.34 |
79839 | CCDC102B | ATC4 | Human | Thyroid | ATC | 8.80e-33 | 9.55e-01 | 0.34 |
79839 | CCDC102B | ATC5 | Human | Thyroid | ATC | 4.74e-67 | 1.24e+00 | 0.34 |
Page: 1 |
![]() |
Tissue | Expression Dynamics | Abbreviation |
Thyroid | ![]() | ATC: Anaplastic thyroid cancer |
HT: Hashimoto's thyroiditis | ||
PTC: Papillary thyroid cancer |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Liver | Cyst | ![]() |
Lung | IAC | ![]() |
Lung | AIS | ![]() |
Lung | AAH | ![]() |
Lung | MIAC | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
CCDC102B | SNV | Missense_Mutation | rs199750681 | c.23G>A | p.Arg8Gln | p.R8Q | Q68D86 | protein_coding | tolerated(0.1) | benign(0.11) | TCGA-A2-A0CX-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | adriamycin | SD |
CCDC102B | SNV | Missense_Mutation | c.610C>A | p.Gln204Lys | p.Q204K | Q68D86 | protein_coding | tolerated(0.78) | benign(0.003) | TCGA-A8-A09Q-01 | Breast | breast invasive carcinoma | Female | >=65 | III/IV | Hormone Therapy | anastrozole | SD | |
CCDC102B | SNV | Missense_Mutation | c.751G>A | p.Glu251Lys | p.E251K | Q68D86 | protein_coding | tolerated(0.08) | benign(0.067) | TCGA-A8-A0A7-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
CCDC102B | SNV | Missense_Mutation | rs368864406 | c.832N>T | p.Arg278Cys | p.R278C | Q68D86 | protein_coding | deleterious(0) | probably_damaging(0.987) | TCGA-AN-A04A-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
CCDC102B | SNV | Missense_Mutation | c.553N>G | p.Arg185Gly | p.R185G | Q68D86 | protein_coding | tolerated(0.24) | benign(0.003) | TCGA-AN-A0AK-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
CCDC102B | SNV | Missense_Mutation | rs368864406 | c.832N>T | p.Arg278Cys | p.R278C | Q68D86 | protein_coding | deleterious(0) | probably_damaging(0.987) | TCGA-AN-A0AK-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
CCDC102B | SNV | Missense_Mutation | rs746788896 | c.485G>T | p.Gly162Val | p.G162V | Q68D86 | protein_coding | tolerated(0.18) | benign(0.077) | TCGA-S3-AA10-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Chemotherapy | cytoxan | CR |
CCDC102B | insertion | In_Frame_Ins | novel | c.272_273insGAATTATGTATCTTTAAAACTTAACTCTGCTTCTCT | p.Thr91_Met92insAsnTyrValSerLeuLysLeuAsnSerAlaSerLeu | p.T91_M92insNYVSLKLNSASL | Q68D86 | protein_coding | TCGA-A8-A09C-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | ||
CCDC102B | deletion | Frame_Shift_Del | novel | c.1079delN | p.Ser361ArgfsTer23 | p.S361Rfs*23 | Q68D86 | protein_coding | TCGA-D8-A27V-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Hormone Therapy | tamoxiphen | SD | ||
CCDC102B | SNV | Missense_Mutation | novel | c.1033N>G | p.Ile345Val | p.I345V | Q68D86 | protein_coding | tolerated(0.14) | benign(0.028) | TCGA-2W-A8YY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
Page: 1 2 3 4 5 6 7 8 9 10 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |